Tesamorelin — Research Overview

Also known as: Egrifta

A synthetic stabilized analog of GHRH studied for its targeted effects on visceral fat reduction, metabolic health improvement, sleep quality, and GH/IGF-1 output. The only GHRH analog with FDA approval, for HIV-associated lipodystrophy under the brand name Egrifta.

Back to Peptide Encyclopedia